论文部分内容阅读
近年来，在肺心病的诊治过程中，发现合并冠心病者日渐增多，其诊断尚无统一的标准，主要是根据临床表现和心电图检查。血清载脂蛋白（APO）检测目前已广泛应用于临床，它与冠心病的关系临床上已有较多的研究，证明血清APO检测是优于常规血脂检测的预测和诊断心血管疾病的生化指标。至于APO与肺心病及肺心病合并冠心病的关系如何，临床研究尚少。本研究的目的旨在通过对血清载脂蛋白A_1（APOA_1），载脂蛋白B（APOB）及APOA_1/APOB的检测对上述问题进行探讨。
In recent years, in the diagnosis and treatment of pulmonary heart disease, found that patients with coronary heart disease is increasing, its diagnosis there is no uniform standard, mainly based on clinical manifestations and ECG. Serum apolipoprotein (APO) test has been widely used in clinical trials, its relationship with coronary heart disease clinically there have been more studies have shown that serum APO test is superior to the conventional blood lipid test prediction and diagnosis of cardiovascular disease biochemical indicators . As for the APO and pulmonary heart disease and pulmonary heart disease with coronary heart disease how, clinical research is still small. The aim of this study was to investigate the above issues by detecting serum apolipoprotein A_1 (APOA_1), apolipoprotein B (APOB) and APOA_1 / APOB.